Generate Biomedicines, Inc. GENB Income Statement
| Q1 '26 | Q1 '25 | ||
|---|---|---|---|
| $7.22M-18.1% | $8.82M— | ||
| $57.81M+23.5% | $46.83M— | ||
| $13.52M+33.3% | $10.15M— | ||
| $71.34M+25.2% | $56.97M— | ||
| $71.34M+25.2% | $56.97M— | ||
| -$64.11M-33.1% | -$48.15M— | ||
| -887.5%-341pp | -546.1%— | ||
| $182K-50.5% | $368K— | ||
| $2.91M-32.0% | $4.28M— | ||
| $2.43M-37.7% | $3.9M— | ||
| -$61.69M-39.4% | -$44.26M— | ||
| $28K-50.0% | $56K— | ||
| -$61.45M-47.4% | -$41.69M— | ||
| -850.6%-378pp | -472.7%— | ||
| -$1.07+34.0% | -$1.62— | ||
| -$1.07+34.0% | -$1.62— | ||
| 64.9M+97.8% | 32.8M— | ||
| 64.9M+97.8% | 32.8M— | ||
| $7.75M-33.2% | $11.59M— | ||
| -$61.53M-47.4% | -$41.76M— | ||
| $58K+441% | -$17K— | ||
| -$82K-15.5% | -$71K— | ||
| $7.22M-18.1% | $8.82M— | ||
| -$64.11M-33.1% | -$48.15M— | ||
| -$60.84M-36.0% | -$44.74M— | ||
| -$60.84M-36.0% | -$44.74M— | ||
| -842.2%-335pp | -507.4%— | ||
| -$64.11M-33.1% | -$48.15M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Generate Biomedicines, Inc. 's income statement data come from?
- Every line is extracted from Generate Biomedicines, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.